Literature DB >> 27686581

Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.

Konstantin Tamarov1, Wujun Xu2, Liubov Osminkina3, Sergey Zinovyev4, Pasi Soininen5, Andrey Kudryavtsev6, Maxim Gongalsky7, Azha Gaydarova8, Ale Närvänen5, Victor Timoshenko3, Vesa-Pekka Lehto9.   

Abstract

One critical functionality of the carrier system utilized in targeted drug delivery is its ability to trigger the release of the therapeutic cargo once the carrier has reached its target. External triggering is an alluring approach as it can be applied in a precise spatiotemporal manner. In the present study, we achieved external triggering through the porous silicon (PSi) nanoparticles (NPs) by providing a pulse of infrared or radiofrequency radiation. The NPs were grafted with a temperature responsive polymer whose critical temperature was tailored to be slightly above 37°C. The polymer coating improved the biocompatibility of the NPs significantly in comparison with their uncoated counterparts. Radiation induced a rapid temperature rise, which resulted in the collapse of the polymer chains facilitating the cargo release. Both infrared and radiofrequency radiation were able to efficiently trigger the release of the encapsulated drug in vitro and induce significant cell death in comparison to the control groups. Radiofrequency radiation was found to be more efficient in vitro, and the treatment efficacy was verified in vivo in a lung carcinoma (3LL) mice model. After a single intratumoral administration of the carrier system combined with radiofrequency radiation, there was clear suppression of the growth of the carcinoma and a prolongation of the survival time of the animals. TOC IMAGE: The temperature responsive (TR) polymer grafted on the surface of porous silicon nanoparticles (PSi NPs) changes its conformation in response to the heating induced by infrared or radiofrequency radiation. The conformation change allows the loaded doxorubicin to escape from the pores, achieving controlled drug release from TR PSi NPs, which displayed efficacy against malignant cells both in vitro and in vivo.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  infrared heating; porous silicon; radiofrequency heating; temperature responsive polymer; triggered drug release

Mesh:

Substances:

Year:  2016        PMID: 27686581     DOI: 10.1016/j.jconrel.2016.09.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  The emergence of nanoporous materials in lung cancer therapy.

Authors:  Deepika Radhakrishnan; Shan Mohanan; Goeun Choi; Jin-Ho Choy; Steffi Tiburcius; Hoang Trung Trinh; Shankar Bolan; Nikki Verrills; Pradeep Tanwar; Ajay Karakoti; Ajayan Vinu
Journal:  Sci Technol Adv Mater       Date:  2022-07-20       Impact factor: 7.821

2.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

Review 3.  Recent advances in hybrid system of porous silicon nanoparticles and biocompatible polymers for biomedical applications.

Authors:  Yuna Jung; Dokyoung Kim
Journal:  Biomed Eng Lett       Date:  2021-06-15

Review 4.  Mesoporous silica nanoparticles for drug and gene delivery.

Authors:  Yixian Zhou; Guilan Quan; Qiaoli Wu; Xiaoxu Zhang; Boyi Niu; Biyuan Wu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2018-02-12       Impact factor: 11.413

5.  Intravital Whole-Process Monitoring Thermo-Chemotherapy Via 2D Silicon Nanoplatform: A Macro Guidance and Long-Term Microscopic Precise Imaging Strategy.

Authors:  Doudou Huang; Guangxing Wang; Jingsong Mao; Chunlei Liu; Zhongxiong Fan; Yunrui Zhang; Bei Zhang; Yang Zhao; Cuixia Dai; Yaqin He; Heng Ma; Gang Liu; Xiaoyuan Chen; Qingliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2021-06-24       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.